Literature DB >> 26973885

Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing.

Hiroki Ando1, Sebastien Lemire1, Diana P Pires2, Timothy K Lu1.   

Abstract

Bacteria are central to human health and disease, but existing tools to edit microbial consortia are limited. For example, broad-spectrum antibiotics are unable to accurately manipulate bacterial communities. Bacteriophages can provide highly specific targeting of bacteria, but assembling well-defined phage cocktails solely with natural phages can be a time-, labor- and cost-intensive process. Here, we present a synthetic-biology strategy to modulate phage host ranges by engineering phage genomes in Saccharomyces cerevisiae. We used this technology to redirect Escherichia coli phage scaffolds to target pathogenic Yersinia and Klebsiella bacteria, and conversely, Klebsiella phage scaffolds to target E. coli by modular swapping of phage tail components. The synthetic phages achieved efficient killing of their new target bacteria and were used to selectively remove bacteria from multi-species bacterial communities with cocktails based on common viral scaffolds. We envision that this approach will accelerate phage-biology studies and enable new technologies for bacterial population editing.

Entities:  

Year:  2015        PMID: 26973885      PMCID: PMC4785837          DOI: 10.1016/j.cels.2015.08.013

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  40 in total

1.  A fully decompressed synthetic bacteriophage øX174 genome assembled and archived in yeast.

Authors:  Paul R Jaschke; Erica K Lieberman; Jon Rodriguez; Adrian Sierra; Drew Endy
Journal:  Virology       Date:  2012-10-15       Impact factor: 3.616

Review 2.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

3.  What is needed for phage therapy to become a reality in Western medicine?

Authors:  Harald Brüssow
Journal:  Virology       Date:  2012-10-09       Impact factor: 3.616

4.  Genome replication, synthesis, and assembly of the bacteriophage T7 in a single cell-free reaction.

Authors:  Jonghyeon Shin; Paul Jardine; Vincent Noireaux
Journal:  ACS Synth Biol       Date:  2012-07-10       Impact factor: 5.110

Review 5.  The next generation of bacteriophage therapy.

Authors:  Timothy K Lu; Michael S Koeris
Journal:  Curr Opin Microbiol       Date:  2011-08-23       Impact factor: 7.934

6.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.

Authors:  Robert J Citorik; Mark Mimee; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2014-09-21       Impact factor: 54.908

7.  Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.

Authors:  Ruth Kiro; Dror Shitrit; Udi Qimron
Journal:  RNA Biol       Date:  2014-01-22       Impact factor: 4.652

8.  The gp38 adhesins of the T4 superfamily: a complex modular determinant of the phage's host specificity.

Authors:  Sabrina N Trojet; Anne Caumont-Sarcos; Elsa Perrody; André M Comeau; H M Krisch
Journal:  Genome Biol Evol       Date:  2011-07-11       Impact factor: 3.416

9.  CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.

Authors:  Bruno Martel; Sylvain Moineau
Journal:  Nucleic Acids Res       Date:  2014-07-24       Impact factor: 16.971

10.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Authors:  David Bikard; Chad W Euler; Wenyan Jiang; Philip M Nussenzweig; Gregory W Goldberg; Xavier Duportet; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2014-10-05       Impact factor: 54.908

View more
  91 in total

Review 1.  Manipulating Bacterial Communities by in situ Microbiome Engineering.

Authors:  Ravi U Sheth; Vitor Cabral; Sway P Chen; Harris H Wang
Journal:  Trends Genet       Date:  2016-02-22       Impact factor: 11.639

2.  Bacterial Endospores as Phage Genome Carriers and Protective Shells.

Authors:  Naiana Gabiatti; Pingfeng Yu; Jacques Mathieu; Grant W Lu; Xifan Wang; Hangjun Zhang; Hugo M Soares; Pedro J J Alvarez
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 4.  Microbiome therapeutics - Advances and challenges.

Authors:  Mark Mimee; Robert J Citorik; Timothy K Lu
Journal:  Adv Drug Deliv Rev       Date:  2016-05-05       Impact factor: 15.470

Review 5.  Decoding molecular interactions in microbial communities.

Authors:  Nicole A Abreu; Michiko E Taga
Journal:  FEMS Microbiol Rev       Date:  2016-07-13       Impact factor: 16.408

Review 6.  Genetically Engineered Phages: a Review of Advances over the Last Decade.

Authors:  Diana P Pires; Sara Cleto; Sanna Sillankorva; Joana Azeredo; Timothy K Lu
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

7.  Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases.

Authors:  Karin Moelling; Felix Broecker
Journal:  Bacteriophage       Date:  2016-10-21

Review 8.  Engineering microbes for targeted strikes against human pathogens.

Authors:  In Young Hwang; Hui Ling Lee; James Guoxian Huang; Yvonne Yijuan Lim; Wen Shan Yew; Yung Seng Lee; Matthew Wook Chang
Journal:  Cell Mol Life Sci       Date:  2018-05-07       Impact factor: 9.261

9.  Engineering Biorthogonal Phage-Based Nanobots for Ultrasensitive, In Situ Bacteria Detection.

Authors:  Hannah S Zurier; Michelle M Duong; Julie M Goddard; Sam R Nugen
Journal:  ACS Appl Bio Mater       Date:  2020-06-23

Review 10.  Understanding and Engineering Distributed Biochemical Pathways in Microbial Communities.

Authors:  Xinyun Cao; Joshua J Hamilton; Ophelia S Venturelli
Journal:  Biochemistry       Date:  2018-11-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.